{"schema_version":"secwatch.filing_event.v1","accession":"0001425450-26-000066","form_type":"8-K","ticker":"KIDS","cik":"0001425450","company_name":"ORTHOPEDIATRICS CORP","filed_at":"2026-08-04T20:08:24+00:00","discovered_at":"2026-08-04T20:09:00.280022+00:00","generated_at":"2026-08-04T20:09:06.740953+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"OrthoPediatrics Q2 revenue $70.5M (+15% YoY), raises FY2026 guidance to $265-269M","bullets":["Q2 2026 revenue $70.5M, up 15% YoY; domestic +14%, international +22%.","Trauma & Deformity revenue $52.6M (+26% YoY); Scoliosis $16.9M (-9% YoY).","Net loss $7.2M ($0.30/share); adjusted EBITDA $6.8M vs $4.1M YoY.","Free cash flow usage improved 78% to $3.1M; cash $47.9M at quarter end.","Raised FY2026 revenue guidance to $265-269M; expects breakeven FCF in 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001425450-26-000066","json":"https://secwatch.observer/filing/0001425450-26-000066.json","markdown":"https://secwatch.observer/filing/0001425450-26-000066.md","text":"https://secwatch.observer/filing/0001425450-26-000066.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1425450/000142545026000066/0001425450-26-000066-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1425450/000142545026000066/kids-20260804.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-04T20:09:06.740953+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}